These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2956241)

  • 1. Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.
    Maisch B; Izumi T
    Heart Vessels Suppl; 1985; 1():8-13. PubMed ID: 2956241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological defects precursors of myocarditis and dilated cardiomyopathy?
    Bolte HD
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():69-71. PubMed ID: 3162035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.
    Maisch B
    Basic Res Cardiol; 1986; 81 Suppl 1():217-41. PubMed ID: 2947566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.
    Schulze K; Becker BF; Schultheiss HP
    Circ Res; 1989 Feb; 64(2):179-92. PubMed ID: 2536302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
    Zhao L; Fu Z
    J Immunol Res; 2018; 2018():5301548. PubMed ID: 29854842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis--incidence and relation to cardiac function and morphology.
    Takemoto M; Kusachi S; Urabe N; Inoue K; Tsuji T
    Jpn Circ J; 1993 Dec; 57(12):1150-8. PubMed ID: 8283607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological cellular regulator and effector mechanisms in myocarditis.
    Maisch B; Bülowius U; Schmier K; Klopf D; Koper D; Sibelis T; Kochsiek K
    Herz; 1985 Feb; 10(1):8-14. PubMed ID: 2858443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity in dilated cardiomyopathy.
    Das SK; Cassidy JT; Huber SA
    Heart Vessels Suppl; 1985; 1():205-8. PubMed ID: 2956236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity in myocarditis: relevance of animal models.
    Huber SA
    Clin Immunol Immunopathol; 1997 May; 83(2):93-102. PubMed ID: 9143370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
    Caforio AL; Mahon NJ; Mckenna WJ
    Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy--clinical and experimental data.
    Schultheiss HP
    Springer Semin Immunopathol; 1989; 11(1):15-30. PubMed ID: 2546261
    [No Abstract]   [Full Text] [Related]  

  • 19. Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease.
    Schwimmbeck PL; Schwimmbeck NK; Schultheiss HP; Strauer BE
    Clin Immunol Immunopathol; 1993 Aug; 68(2):135-40. PubMed ID: 7689426
    [No Abstract]   [Full Text] [Related]  

  • 20. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.
    Mascaro-Blanco A; Alvarez K; Yu X; Lindenfeld J; Olansky L; Lyons T; Duvall D; Heuser JS; Gosmanova A; Rubenstein CJ; Cooper LT; Kem DC; Cunningham MW
    Autoimmunity; 2008 Sep; 41(6):442-53. PubMed ID: 18781470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.